Kyverna Therapeutics (KYTX) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.13
-0.97
-0.82
-0.67

Details

Expected EPS
-1.125719
Actual EPS
-1.03
Surprise EPS
0.1
Surprise Percent
+8.5%

Description

Kyverna Therapeutics (KYTX) has reported earnings of -1.03 per share for Q2 2025.

0 Comments

Share your thoughts